IL98979A - Pharmaceutical preparations containing benzothiazol derivatives and their use in lowering the urinary level in the blood - Google Patents

Pharmaceutical preparations containing benzothiazol derivatives and their use in lowering the urinary level in the blood

Info

Publication number
IL98979A
IL98979A IL9897991A IL9897991A IL98979A IL 98979 A IL98979 A IL 98979A IL 9897991 A IL9897991 A IL 9897991A IL 9897991 A IL9897991 A IL 9897991A IL 98979 A IL98979 A IL 98979A
Authority
IL
Israel
Prior art keywords
uric acid
acid levels
formula
hydroxy
compound
Prior art date
Application number
IL9897991A
Other languages
English (en)
Hebrew (he)
Other versions
IL98979A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL98979A0 publication Critical patent/IL98979A0/xx
Publication of IL98979A publication Critical patent/IL98979A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL9897991A 1990-08-02 1991-07-27 Pharmaceutical preparations containing benzothiazol derivatives and their use in lowering the urinary level in the blood IL98979A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/562,096 US5064830A (en) 1990-08-02 1990-08-02 Lowering of blood uric acid levels

Publications (2)

Publication Number Publication Date
IL98979A0 IL98979A0 (en) 1992-07-15
IL98979A true IL98979A (en) 1996-11-14

Family

ID=24244779

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9897991A IL98979A (en) 1990-08-02 1991-07-27 Pharmaceutical preparations containing benzothiazol derivatives and their use in lowering the urinary level in the blood

Country Status (16)

Country Link
US (1) US5064830A (ko)
EP (1) EP0469837B1 (ko)
JP (1) JPH04234321A (ko)
KR (1) KR940002665B1 (ko)
AT (1) ATE113840T1 (ko)
AU (1) AU622590B2 (ko)
CA (1) CA2048235C (ko)
DE (1) DE69105069T2 (ko)
DK (1) DK0469837T3 (ko)
HU (1) HUT61665A (ko)
IE (1) IE64046B1 (ko)
IL (1) IL98979A (ko)
MX (1) MX9100450A (ko)
NZ (1) NZ239215A (ko)
PT (1) PT98509B (ko)
ZA (1) ZA916060B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391551A (en) * 1993-05-10 1995-02-21 Pfizer Inc. Method of lowering blood lipid levels
IL120264A0 (en) * 1996-02-29 1997-06-10 Pfizer Method of reducing tissue damage associated with non-cardiac ischemia
IL124236A (en) * 1997-05-05 2003-01-12 Pfizer Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
JP5806221B2 (ja) * 2009-10-13 2015-11-10 ウェルスタット セラピューティクス コーポレイション 尿酸を減少させる３−置換化合物
WO2017176777A1 (en) * 2016-04-04 2017-10-12 Aviragen Therapeutics, Inc. Bta-c585 for the treatment and/or prevention of conditions related to or associated with hyperuricemia or hyperuricosuria and other conditions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939140A (en) * 1985-11-07 1990-07-03 Pfizer Inc. Heterocyclic oxophthalazinyl acetic acids
ES2032749T3 (es) * 1985-11-07 1993-03-01 Pfizer Inc. Acidos oxoftalazinil-aceticos heterociclicos.
GB8704569D0 (en) * 1987-02-26 1987-04-01 Ici America Inc Therapeutic agent
JPH0676391B2 (ja) * 1987-06-09 1994-09-28 フアイザー・インコーポレイテツド ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法
EP0322153A3 (en) * 1987-12-21 1990-08-16 Pfizer Inc. Heterocyclic oxophtalazinyl acetic acids

Also Published As

Publication number Publication date
HU912567D0 (en) 1992-01-28
AU622590B2 (en) 1992-04-09
IE912721A1 (en) 1992-02-12
US5064830A (en) 1991-11-12
DK0469837T3 (da) 1994-12-27
DE69105069T2 (de) 1995-03-09
EP0469837A2 (en) 1992-02-05
PT98509B (pt) 1999-01-29
NZ239215A (en) 1997-07-27
KR920003970A (ko) 1992-03-27
HUT61665A (en) 1993-03-01
IE64046B1 (en) 1995-06-28
EP0469837B1 (en) 1994-11-09
AU8156091A (en) 1992-02-06
IL98979A0 (en) 1992-07-15
MX9100450A (es) 1992-04-01
DE69105069D1 (de) 1994-12-15
JPH04234321A (ja) 1992-08-24
PT98509A (pt) 1992-06-30
ATE113840T1 (de) 1994-11-15
KR940002665B1 (ko) 1994-03-28
CA2048235C (en) 1995-05-30
EP0469837A3 (en) 1992-04-08
ZA916060B (en) 1993-03-31

Similar Documents

Publication Publication Date Title
AU724327B2 (en) Method of reducing tissue damage associated with non-cardiac ischemia
US5393772A (en) Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation
JP2789134B2 (ja) 糖尿病の合併症を制御する置換ピリミジン類
MA27389A1 (fr) Derives de benzimidazole nouveaux utiles comme agents antiproliferatifs.
CA2048235C (en) Lowering of blood uric acid levels
US5990111A (en) Aldose reductase inhibition in preventing or reversing diabetic cardiomyopathy
HU199684B (en) Process for producing pharmaceutical compositions containing 2-pyrimidinyl-1-piperazin derivatives against alcoholism
JP3153070B2 (ja) 血中脂質レベルを低下させる方法
EP0132994B1 (en) Compounds for lowering lipid levels
EP0319288B1 (en) dl-5-[(2-benzyl-3,4-dihydro-2H-benzopyran-6-yl)methyl]thiazolidine-2,4-dione as an anti-atherosclerosis agent
CA2024181C (en) Method of treating chemical dependencies using sertraline
IL89401A (en) Medicaments containing 1,4-dihydropyridine derivatives for the treatment of alcohol addiction and their preparation
EP0091193B1 (en) Antidiabetic compositions
JPS62158216A (ja) 薬物の製造方法
US4978667A (en) Substituted 6H-7,8-dihydrothiapyrano(3,2-d)-pyrimidines as hypoglycemic agents
JP3034169B2 (ja) 活性酸素種の消去剤
US3941888A (en) Substituted or unsubstituted p-alkanoyl toluenes as hypolipidemics
WO1996007415B1 (en) Myocardial protection using benzothiazepinones
JPS62108816A (ja) 血糖低下剤としての置換６Ｈ−７，８−ジヒドロチアピラノ−〔３，２−ｄ〕ピリミジン
MXPA96005153A (en) Pharmaceutical agents for the treatment of chronic and agu inflammatory diseases

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
RH Patent void